News
CHJTF
1.390
NaN%
--
CSPC Wins U.S. FDA Nod to Trial Novel Inhaled Drug for Pulmonary Fibrosis
TipRanks · 03/06 12:13
CSPC Wins China Trial Nod for Once-Daily Asthma Inhalation Therapy
TipRanks · 03/05 11:45
CSPC Wins China Trial Nod for Hemophilia A Biosimilar Emicizumab
TipRanks · 03/04 11:44
CSPC Pharmaceutical Adds Capital Markets Veteran Zhang Yiwei to Board
TipRanks · 03/02 13:52
CSPC Pharmaceutical Updates Board Composition and Committee Roles
TipRanks · 03/02 13:52
CSPC Wins U.S. FDA Nod for Trial of Novel Rapid-Dissolving Paclitaxel for Metastatic Breast Cancer
TipRanks · 03/02 13:50
Guotai Haitong Keeps Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
TipRanks · 02/27 05:05
CSPC Pharmaceutical Unit to Divest 30% Stake in Connected Party Deal
TipRanks · 02/26 10:39
China drug licensing deals surge nearly 10-fold in value since 2021
Seeking Alpha · 02/19 18:31
CSPC Wins China Trial Nod for Ultra-Long-Acting Post-Operative Pain Injection
TipRanks · 02/16 05:37
CSPC Wins U.S. FDA Nod for Monthly GLP-1/GIP Obesity Injection Trial
TipRanks · 02/16 05:37
AstraZeneca rises as cancer drugs power Q4 beat
Seeking Alpha · 02/10 12:39
Bernstein Sticks to Their Hold Rating for CSPC Pharmaceutical Group (CHJTF)
TipRanks · 02/09 16:36
Huatai Securities Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
TipRanks · 02/03 06:25
Goldman Sachs Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
TipRanks · 02/02 12:46
Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), CSPC Pharmaceutical Group (CHJTF)
TipRanks · 02/02 12:40
CSPC Wins China Approval for Fast-Acting Intravenous Hypertension Drug
TipRanks · 02/02 12:10
CICC Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)
TipRanks · 01/31 17:05
AstraZeneca strikes up to $18.5B obesity drug deal with China’s CSPC Pharmaceutical
Seeking Alpha · 01/30 08:19
CSPC Strikes US$1.2 Billion AstraZeneca Deal for Long-Acting Peptide and Obesity Drugs
TipRanks · 01/30 00:11
More
Webull provides a variety of real-time CHJTF stock news. You can receive the latest news about Cspc Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About CHJTF
CSPC Pharmaceutical Group Ltd is an investment holding company primarily engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The Company conducts its business in the domestic and overseas markets.